JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy
The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.
The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.
What's Your Reaction?
